- Home
- About
- Find staff
- Markus Hansson
Markus Hansson
Professor/ Chief Physician
Department of Internal Medicine and Clinical-
Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide
therapy
Sandra Askman, Julia Westerlund, Asa Pettersson, Thomas Hellmark, Asa Johansson, Stina Wichert, Markus Hansson
EUROPEAN JOURNAL OF HAEMATOLOGY - 2024 -
Impact of 1q gains on treatment outcomes of patients with newly diagnosed multiple myeloma in a real-world Swedish population receiving modern
treatment
K. Lemonakis, L. Olsson-Arvidsson, C. Karlsson, B. Johansson, Markus Hansson
European Journal of Haematology - 2023 -
Epidemiology and clinical outcomes of light-chain amyloidosis in Sweden: A nationwide population-based
study
U. H. Mellqvist, Q. Cai, L. L. Hester, M. Grovdal, J. Borsum, I. Rahman, E. M. Ammann, Markus Hansson
European Journal of Haematology - 2023 -
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte
globulin
Mikael Lisak, Malin Nicklasson, Robert Palmason, Stina Wichert, Cecila Isaksson, Per-Ola Andersson, Jan-Erik Johansson, Stig Lenhoff, Mats Brune, Markus Hansson
Scientific Reports - 2023 -
Computed tomography with adjusted dose for body mass index may be superior to whole-body radiography especially in elderly patients with multiple
myeloma
L. Weber, Markus Hansson, Mats Geijer
Acta Radiologica - 2023 -
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple
Myeloma
F. Schjesvold, B. Paiva, V. Ribrag, P. Rodriguez-Otero, J. F. San-Miguel, P. Robak, Markus Hansson, M. Onishi, H. Hamidi, V. Malhi, M. Dail, A. Javery, G. Ku, M. S. Raab
Clinical Lymphoma, Myeloma and Leukemia - 2023 -
Suppression of T-Cell Proliferation by Normal Density Granulocytes Led to CD183 Downregulation and Cytokine Inhibition in
T-Cells
J. Westerlund, S. Askman, Å. Pettersson, T. Hellmark, C. M. Johansson, Markus Hansson
Journal of Immunology Research - 2022 -
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple
Myeloma
Paul G. Richardson, Shaji K. Kumar, Tamás Masszi, Norbert Grzasko, Nizar J. Bahlis, Markus Hansson, Luděk Pour, Irwindeep Sandhu, Peter Ganly, Bartrum W. Baker, Sharon R. Jackson, Anne Marie Stoppa, Peter Gimsing, Laurent Garderet, Cyrille Touzeau, Francis K. Buadi, Jacob P. Laubach, Michele Cavo, Mohamed Darif, Richard Labotka, Deborah Berg, Philippe Moreau
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 2021 -
Incidence, mortality and survival in multiple myeloma compared to other hematopoietic neoplasms in Sweden up to year
2016
Kari Hemminki, Asta Försti, Markus Hansson
Scientific Reports - 2021 -
Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell
Activity
J. Petersson, S. Askman, A. Pettersson, S. Wichert, T. Hellmark, A. C. M. Johansson, Markus Hansson
Journal of Immunology Research - 2021